Skip to main content
. 2023 Jul 28;18(7):e0288791. doi: 10.1371/journal.pone.0288791

Fig 3. Reduced migration ability of breast and lung cancer cell lines after AdOx treatment.

Fig 3

(a) Representative images from wound healing assay of MDA-MB-231, MCF-7, H292 and A549 treated with 20μM AdOx or the vehicle (DMSO) for 24, 48 and 72h. (b) The percentage of the wound closure covered by migrated cells was quantified and shown as the mean ± SD of three independent experiments. The data demonstrates a statistically significant reduction in migration for AdOx-treated cells compared to the cells treated with the control, DMSO. The scale bar is 400 μm. Significant results were denoted by asterisks (*P < 0.05; **P < 0.01 and ***P < 0.001).